Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Integrasi pengetahuan lokal sebagai solusi iklim: Belajar dari masyarakat adat Bayan di Lombok

● Masyarakat adat Bayan di Lombok Utara, NTB, punya Wariga sebagai sistem pengetahuan alam yang presisi.● Ada juga arsitektur Bale Bayan yang terbukti tahan gempa dan sistem ‘awiq-aw...

Tan Malaka untuk pemula: Sejauh mana kita bisa mempercayai mitos?

● ‘Madilog’ karya Tan Malaka mengajak masyarakat Indonesia meninggalkan cara berpikir mistik dan beralih ke logika ilmiah.● Mitos dan rasio bukanlah lawan, melainkan dua bentuk...

Kenaikan harga tiket Transjakarta: Antara kemampuan masyarakat dan beban pemda Jakarta

● Setelah 2 dekade, harga tiket Transjakarta bakal naik.● Pemerintah daerah Jakarta sedang menghadapi paceklik sehingga harus mengurangi subsidi.● Jika kenaikan harga tiket lebih tin...